5262-39-5 | N-Oxalylglycine

Packsize	Purity	Availability	Price	Discounted Price
5mg	98%	in stock	$42.00	$29.00
100mg	98%	in stock	$58.00	$40.00
250mg	98%	in stock	$70.00	$49.00
1g	98%	in stock	$145.00	$101.00
5g	98%	in stock	$505.00	$353.00
10g	98%	in stock	$922.00	$646.00
25g	98%	in stock	$1,844.00	$1,291.00

Description

• Catalog Number: AI51813
• Chemical Name: N-Oxalylglycine
• CAS Number: 5262-39-5
• Molecular Formula: C4H5NO5
• Molecular Weight: 147.0862
• MDL Number: MFCD00913253
• SMILES: OC(=O)CNC(=O)C(=O)O

Computed Properties

• Complexity: 175
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 3
• XLogP3: -0.9

Literature

• The stabilization of hypoxia inducible factor modulates differentiation status and inhibits the proliferation of mouse embryonic stem cells.

  Chemico-biological interactions 20160125

• Featured Article: Hypoxia-inducible factor-1α dependent nuclear entry of factor inhibiting HIF-1.

  Experimental biology and medicine (Maywood, N.J.) 20151101

• Targeting the hypoxia-sensing pathway in clinical hematology.

  Stem cells translational medicine 20140201

• Cobalt stimulates HIF-1-dependent but inhibits HIF-2-dependent gene expression in liver cancer cells.

  The international journal of biochemistry & cell biology 20131101

• Selective stabilization of HIF-1α in renal tubular cells by 2-oxoglutarate analogues.

  The American journal of pathology 20121101

• Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor in dental pulp-derived cells.

  Journal of endodontics 20121101

• α-Ketoglutarate-related inhibitors of HIF prolyl hydroxylases are substrates of renal organic anion transporters 1 (OAT1) and 4 (OAT4).

  Pflugers Archiv : European journal of physiology 20121001

• Activation of the prolyl-hydroxylase oxygen-sensing signal cascade leads to AMPK activation in cardiomyocytes.

  Journal of cellular and molecular medicine 20120901

• Increased activation of the hypoxia-inducible factor pathway in varicose veins.

  Journal of vascular surgery 20120501

• Mechanistic studies on the application of DNA aptamers as inhibitors of 2-oxoglutarate-dependent oxygenases.

  Journal of medicinal chemistry 20120412

• Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor by periodontal fibroblasts.

  Journal of periodontal research 20120401

• Dynamic combinatorial mass spectrometry leads to inhibitors of a 2-oxoglutarate-dependent nucleic acid demethylase.

  Journal of medicinal chemistry 20120308

• HIF-1α induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice.

  Journal of hepatology 20120201

• Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α.

  Neurobiology of disease 20120201

• Hypoxia and hypoxia mimetics inhibit TNF-dependent VCAM1 induction in the 5A32 endothelial cell line via a hypoxia inducible factor dependent mechanism.

  Journal of dermatological science 20120201

• Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D.

  PloS one 20120101

• Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells.

  PloS one 20120101

• Hypoxia-inducible factor activation protects the kidney from gentamicin-induced acute injury.

  PloS one 20120101

• Inverse correlation between metallothioneins and hypoxia-inducible factor 1 alpha in colonocytes and experimental colitis.

  Biochemical and biophysical research communications 20111216

• Activation of hypoxia-inducible factor-1 ameliorates postischemic renal injury via inducible nitric oxide synthase.

  Molecular and cellular biochemistry 20111201

• Dimethyloxalyglycine stimulates the early stages of gastrointestinal repair processes through VEGF-dependent mechanisms.

  Laboratory investigation; a journal of technical methods and pathology 20111201

• Activation of hypoxia-inducible factor-1 protects airway epithelium against oxidant-induced barrier dysfunction.

  American journal of physiology. Lung cellular and molecular physiology 20111201

• Hypoxia induced expression of histone lysine demethylases: implications in oxygen-dependent retinal neovascular diseases.

  Biochemical and biophysical research communications 20111118

• Hypoxia-inducible factor regulates expression of surfactant protein in alveolar type II cells in vitro.

  American journal of respiratory cell and molecular biology 20111101

• Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells.

  Molecular nutrition & food research 20111101

• Longitudinal quantification of inflammation in the murine dextran sodium sulfate-induced colitis model using μPET/CT.

  Inflammatory bowel diseases 20111001

• Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor.

  Hypertension (Dallas, Tex. : 1979) 20110901

• The hydroxylase inhibitor dimethyloxallyl glycine attenuates endotoxic shock via alternative activation of macrophages and IL-10 production by B1 cells.

  Shock (Augusta, Ga.) 20110901

• Dimethyloxalylglycine stabilizes HIF-1α in cultured human endothelial cells and increases random-pattern skin flap survival in vivo.

  Plastic and reconstructive surgery 20110801

• Systemic pretreatment with dimethyloxalylglycine increases myocardial HIF-1α and VEGF production and improves functional recovery after acute ischemia/reperfusion.

  Surgery 20110801

• Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells.

  The Journal of surgical research 20110515

• Metabolic reprogramming by HIF-1 promotes the survival of bone marrow-derived angiogenic cells in ischemic tissue.

  Blood 20110505

• [Effects of dimethyloxalyl glycine on hypoxic-ischemic brain damage in newborn rats].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20110501

• Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor.

  Journal of immunology (Baltimore, Md. : 1950) 20110401

• Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis.

  British journal of cancer 20110329

• HIF1alpha synergizes with glucocorticoids to promote BFU-E progenitor self-renewal.

  Blood 20110324

• Structural basis for human PHF2 Jumonji domain interaction with metal ions.

  Journal of molecular biology 20110211

• Hydroxylase inhibition attenuates colonic epithelial secretory function and ameliorates experimental diarrhea.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20110201

• Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20110101

• Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.

  Biological & pharmaceutical bulletin 20110101

• Chemical biology of lysine demethylases.

  Current chemical genomics 20110101

• Methods for Activity Analysis of the Proteins that Regulate Histone Methylation.

  Current chemical genomics 20110101

• Activation of Hif1α by the prolylhydroxylase inhibitor dimethyoxalyglycine decreases radiosensitivity.

  PloS one 20110101

• von Hippel-Lindau β-domain-luciferase fusion protein as a bioluminescent hydroxyproline sensor for a hypoxia-inducible factor prolyl hydroxylase assay.

  Analytical biochemistry 20101215

• Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockade.

  American journal of physiology. Renal physiology 20101201

• Hydroxylase inhibition abrogates TNF-alpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD.

  Journal of immunology (Baltimore, Md. : 1950) 20101115

• Structural basis for binding of cyclic 2-oxoglutarate analogues to factor-inhibiting hypoxia-inducible factor.

  Bioorganic & medicinal chemistry letters 20101015

• Hypoxia and preeclampsia: increased expression of urocortin 2 and urocortin 3.

  Reproductive sciences (Thousand Oaks, Calif.) 20100901

• Force field design and molecular dynamics simulations of factor-inhibiting HIF-1 and its complex with known inhibitors: implications for rational inhibitor design.

  Journal of molecular graphics & modelling 20100901

• Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors.

  Journal of medicinal chemistry 20100812

• Acute hypoxia induces HIF-independent monocyte adhesion to endothelial cells through increased intercellular adhesion molecule-1 expression: the role of hypoxic inhibition of prolyl hydroxylase activity for the induction of NF-kappa B.

  Journal of immunology (Baltimore, Md. : 1950) 20100801

• Hydroxylase inhibition reduces synaptic transmission and protects against a glutamate-induced ischemia in the CA1 region of the rat hippocampus.

  Neuroscience 20100602

• Regulation of the matricellular proteins CYR61 (CCN1) and NOV (CCN3) by hypoxia-inducible factor-1{alpha} and transforming-growth factor-{beta}3 in the human trophoblast.

  Endocrinology 20100601

• Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway.

  The Journal of biological chemistry 20100319

• Characterization of connective tissue growth factor expression in primary cultures of human tubular epithelial cells: modulation by hypoxia.

  American journal of physiology. Renal physiology 20100301

• FoxO proteins mediate hypoxic induction of connective tissue growth factor in endothelial cells.

  The Journal of biological chemistry 20100212

• Using NMR solvent water relaxation to investigate metalloenzyme-ligand binding interactions.

  Journal of medicinal chemistry 20100128

• Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1alpha.

  Basic research in cardiology 20100101

• Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20100101

• Increased chemoresistance induced by inhibition of HIF-prolyl-hydroxylase domain enzymes.

  Cancer science 20100101

• Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors.

  PloS one 20100101

• Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression.

  Arteriosclerosis, thrombosis, and vascular biology 20091201

• Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma.

  International journal of colorectal disease 20091101

• Hypoxia interferes with connective tissue growth factor (CTGF) gene expression in human proximal tubular cell lines.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20091101

• 2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.

  Bioorganic & medicinal chemistry letters 20091101

• Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20091001

• Interferon-gamma induces prolyl hydroxylase (PHD)3 through a STAT1-dependent mechanism in human endothelial cells.

  Arteriosclerosis, thrombosis, and vascular biology 20090901

• Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.

  Proceedings of the National Academy of Sciences of the United States of America 20090630

• Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors.

  Bioorganic & medicinal chemistry letters 20090515

• Application of a proteolysis/mass spectrometry method for investigating the effects of inhibitors on hydroxylase structure.

  Journal of medicinal chemistry 20090514

• Prolyl hydroxylase inhibitors depend on extracellular glucose and hypoxia-inducible factor (HIF)-2alpha to inhibit cell death caused by nerve growth factor (NGF) deprivation: evidence that HIF-2alpha has a role in NGF-promoted survival of sympathetic neurons.

  Molecular pharmacology 20090501

• Prolyl hydroxylase inhibitor dimethyloxalylglycine enhances mesenchymal stem cell survival.

  Journal of cellular biochemistry 20090401

• Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.

  Molecular & cellular proteomics : MCP 20090301

• Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease.

  Nature reviews. Drug discovery 20090201

• HIF-1 attenuates Ref-1 expression in endothelial cells: reversal by siRNA and inhibition of geranylgeranylation.

  Vascular pharmacology 20090101

• Prolyl hydroxylase inhibition attenuates post-ischemic cardiac injury via induction of endoplasmic reticulum stress genes.

  Vascular pharmacology 20090101

• Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factors.

  PloS one 20090101

• Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha.

  The Biochemical journal 20081215

• A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}.

  Molecular cancer therapeutics 20081201

• Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.

  Journal of medicinal chemistry 20081127

• HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model.

  Neurobiology of disease 20080901

• Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning.

  Circulation 20080708

• O(2)-sensing signal cascade: clamping of O(2) respiration, reduced ATP utilization, and inducible fumarate respiration.

  American journal of physiology. Cell physiology 20080701

• Overall kinetic mechanism of saccharopine dehydrogenase (L-glutamate forming) from Saccharomyces cerevisiae.

  Biochemistry 20080513

• Induction of carbonic anhydrase IX by hypoxia and chemical disruption of oxygen sensing in rat fibroblasts and cardiomyocytes.

  Pflugers Archiv : European journal of physiology 20080501

• DHEA decreases HIF-1alpha accumulation under hypoxia in human pulmonary artery cells: potential role in the treatment of pulmonary arterial hypertension.

  The Journal of steroid biochemistry and molecular biology 20080301

• The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis.

  Gastroenterology 20080101

• Role of hypoxia-inducible factor 1 alpha in the integrity of articular cartilage in murine knee joints.

  Arthritis research & therapy 20080101

• Prolyl hydroxylase inhibitors delay neuronal cell death caused by trophic factor deprivation.

  Journal of neurochemistry 20071201

• HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes.

  American journal of physiology. Endocrinology and metabolism 20071201

• Hypoxia-inducible factor 1alpha is involved in the prostaglandin metabolism of osteoarthritic cartilage through up-regulation of microsomal prostaglandin E synthase 1 in articular chondrocytes.

  Arthritis and rheumatism 20071201

• Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of insigs.

  The Journal of biological chemistry 20070914

• Effect of chemical stabilizers of hypoxia-inducible factors on early lung development.

  American journal of physiology. Lung cellular and molecular physiology 20070901

• HIF stabilizing agents: shotgun or scalpel?

  American journal of physiology. Lung cellular and molecular physiology 20070901

• Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.

  Acta physiologica (Oxford, England) 20070601

• Purification and characterization of the FeII- and alpha-ketoglutarate-dependent xanthine hydroxylase from Aspergillus nidulans.

  Biochemistry 20070508

• Hypoxia inducible factor-1 modulates hemin-induced IL-8 secretion in microvascular endothelium.

  Microvascular research 20070501

• Toxic effects of cobalt in primary cultures of mouse astrocytes. Similarities with hypoxia and role of HIF-1alpha.

  Biochemical pharmacology 20070301

• The prolyl hydroxylase oxygen-sensing pathway is cytoprotective and allows maintenance of mitochondrial membrane potential during metabolic inhibition.

  American journal of physiology. Cell physiology 20070201

• Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway.

  Oncogene 20070111

• Expression of HIF prolyl hydroxylase isozymes in growth plate chondrocytes: relationship between maturation and apoptotic sensitivity.

  Journal of cellular physiology 20070101

• Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways.

  The Journal of biological chemistry 20060602

• Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes.

  Biochemical and biophysical research communications 20060310

• [HIF-1alpha, HIF-2alpha and VHL mRNA expression in different cell lines during hypoxia].

  Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20060101

• Kinetic and spectroscopic investigation of CoII, NiII, and N-oxalylglycine inhibition of the FeII/alpha-ketoglutarate dioxygenase, TauD.

  Biochemical and biophysical research communications 20051209

• HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation.

  American journal of physiology. Heart and circulatory physiology 20050801

• Activation of hypoxia-induced transcription in normoxia.

  Experimental cell research 20050515

• Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation--implications for prolyl hydroxylase activity and iron.

  Experimental cell research 20050515

• Oligomycin inhibits HIF-1alpha expression in hypoxic tumor cells.

  American journal of physiology. Cell physiology 20050501

• Expression and hypoxia-responsiveness of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 in mammary gland malignant cell lines.

  Acta biochimica Polonica 20050101

• Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice.

  The Journal of physiology 20041001

• Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha.

  The Journal of biological chemistry 20021018